Haisma HJ - Search Results

1

Human IgM monoclonal antibody 16.88: pharmacokinetics and distribution in mouse and man.

Haisma HJ, Kessel MA, Silva C, van Muijen M, Roos JC, Bril H, Martens HJ, McCabe R, Boven E. Haisma HJ, et al. Br J Cancer Suppl. 1990 Jul;10:40-3. Br J Cancer Suppl. 1990. PMID: 2383479 Free PMC article.

2

Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies directed against intracellular antigens.

Haisma HJ, Pinedo HM, Silva CA, Boven E. Haisma HJ, et al. J Immunol Methods. 1992 Sep 18;154(1):55-60. doi: 10.1016/0022-1759(92)90212-c. J Immunol Methods. 1992. PMID: 1401943

3

A monoclonal antibody-beta-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer.

Haisma HJ, Boven E, van Muijen M, de Jong J, van der Vijgh WJ, Pinedo HM. Haisma HJ, et al. Br J Cancer. 1992 Sep;66(3):474-8. doi: 10.1038/bjc.1992.298. Br J Cancer. 1992. PMID: 1520585 Free PMC article.

4

Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate.

Haisma HJ, Boven E, van Muijen M, De Vries R, Pinedo HM. Haisma HJ, et al. Cancer Immunol Immunother. 1992;34(5):343-8. doi: 10.1007/BF01741556. Cancer Immunol Immunother. 1992. PMID: 1540981 Free PMC article.

5

Human IgM monoclonal antibody 16.88: pharmacokinetics and immunogenicity in colorectal cancer patients.

Haisma HJ, Pinedo HM, Kessel MA, van Muijen M, Roos JC, Plaizier MA, Martens HJ, DeJager R, Boven E. Haisma HJ, et al. J Natl Cancer Inst. 1991 Dec 18;83(24):1813-9. doi: 10.1093/jnci/83.24.1813. J Natl Cancer Inst. 1991. PMID: 1744925

6

Tumour localisation with 131I-labelled human IgM monoclonal antibody 16.88 in advanced colorectal cancer patients.

Boven E, Haisma HJ, Bril H, Martens HJ, van Lingen A, den Hollander W, Kessel MA, DeJager RL, Roos JC. Boven E, et al. Among authors: haisma hj. Eur J Cancer. 1991;27(11):1430-6. doi: 10.1016/0277-5379(91)90025-9. Eur J Cancer. 1991. PMID: 1835859

7

Distribution and kinetics of 131I-labeled human IgM monoclonal antibody 16.88 in patients with advanced colorectal cancer.

Roos JC, Plaizier MA, van Lingen A, Haisma HJ, den Hollander W, Martens HJ, Nauta JJ, Dejager RL, Teule GJ, Boven E. Roos JC, et al. Among authors: haisma hj. In Vivo. 1993 Nov-Dec;7(6A):503-9. In Vivo. 1993. PMID: 8193268

8

A monoclonal antibody against human beta-glucuronidase for application in antibody-directed enzyme prodrug therapy.

Haisma HJ, Van Muijen M, Scheffer G, Scheper RJ, Pinedo HM, Boven E. Haisma HJ, et al. Hybridoma. 1995 Aug;14(4):377-82. doi: 10.1089/hyb.1995.14.377. Hybridoma. 1995. PMID: 8522350

9

Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.

Kievit E, Pinedo HM, Schlüper HM, Haisma HJ, Boven E. Kievit E, et al. Among authors: haisma hj. Br J Cancer. 1996 Feb;73(4):457-64. doi: 10.1038/bjc.1996.81. Br J Cancer. 1996. PMID: 8595159 Free PMC article.

10

Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancer.

Kievit E, Pinedo HM, Schlüper HM, Haisma HJ, Boven E. Kievit E, et al. Among authors: haisma hj. Int J Cancer. 1997 Apr 10;71(2):237-45. doi: 10.1002/(sici)1097-0215(19970410)71:2<237::aid-ijc19>3.0.co;2-e. Int J Cancer. 1997. PMID: 9139849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters